Welcome to LookChem.com Sign In|Join Free
  • or
4-(4-isopropylphenyl)-pyridine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

108874-81-3

Post Buying Request

108874-81-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

108874-81-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 108874-81-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,8,7 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 108874-81:
(8*1)+(7*0)+(6*8)+(5*8)+(4*7)+(3*4)+(2*8)+(1*1)=153
153 % 10 = 3
So 108874-81-3 is a valid CAS Registry Number.

108874-81-3Relevant academic research and scientific papers

Synthesis of functionalized 4-phenyl-pyridines via electrochemically prepared organozinc reagents

Gall, Erwan Le,Gosmini, Corinne,Nédélec, Jean-Yves,Périchon, Jacques

, p. 1923 - 1927 (2001)

The efficient and convenient synthesis of various functionalized 4-phenyl-pyridines 2 is described. The key step of the procedure is the electrochemical formation of aromatic organozinc reagents 1 and their coupling with pyridinium salts. Intermediate 1,4

C-F activation for C(sp2)-C(sp3) cross-coupling by a secondary phosphine oxide (SPO)-nickel complex

Müller, Valentin,Ghorai, Debasish,Capdevila, Lorena,Messinis, Antonis M.,Ribas, Xavi,Ackermann, Lutz

supporting information, p. 7034 - 7040 (2020/09/15)

A secondary phosphine oxide (SPO)-nickel catalyst allowed the activation of otherwise inert C-F bonds of unactivated arenes in terms of challenging couplings with primary and secondary alkyl Grignard reagents. The C-F activation is characterized by mild reaction conditions and high levels of branched selectivity. Electron-rich and electron-deficient arenes were suitable electrophiles for this transformation. In addition, this strategy also proved suitable to heterocycles and for the activation of C-O bonds under slightly modified conditions.

COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE

-

Page/Page column 99, (2008/06/13)

The present invention relates to methods, compounds, and compositions for treating or preventing diseases associated with nonsense mutations in an mRNA by administering the compounds or compositions of the present invention. More particularly, the present invention relates to methods, compounds, and compositions for suppressing premature translation termination associated with a nonsense mutation in an mRNA.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 108874-81-3